2018
Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors
Strosberg D, Schneider EB, Onesti J, Saunders N, Konda B, Shah M, Dillhoff M, Schmidt CR, Shirley LA. Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors. Annals Of Surgical Oncology 2018, 25: 3613-3620. PMID: 30182331, DOI: 10.1245/s10434-018-6741-x.Peer-Reviewed Original ResearchConceptsRepeat transarterial chemoembolizationMetastatic neuroendocrine tumorsTransarterial chemoembolizationPancreastatin levelsNeuroendocrine tumorsOverall survivalPrognostic impactImproved overall survivalProgressive liver diseaseFirst transarterial chemoembolizationWorse overall survivalUseful prognostic indicatorLong-term survivalPg/mLConclusionsFor patientsPost TACECarcinoid syndromeTACE treatmentLiver metastasesPatient demographicsImproved survivalLiver diseasePoor outcomePrognostic indicatorResultsA total
2013
Post-treatment surveillance of patients with colorectal cancer with surgically treated liver metastases
Hyder O, Dodson R, Mayo S, Schneider E, Weiss M, Herman J, Wolfgang C, Pawlik T. Post-treatment surveillance of patients with colorectal cancer with surgically treated liver metastases. Surgery 2013, 154: 256-265. PMID: 23889953, PMCID: PMC4048030, DOI: 10.1016/j.surg.2013.04.021.Peer-Reviewed Original ResearchConceptsColorectal liver metastasesMagnetic resonance imagingPositron emission tomographyPost-treatment surveillanceComputed tomographyLiver metastasesLiver resectionSurveillance imagingTreatment of CRLMMore frequent surveillanceMedian survival durationAbdominal computed tomographyPopulation-based patternsLong-term survivalIntensity of surveillanceOverall survivalMedian ageSurveillance guidelinesColorectal cancerMedicare databaseSecondary interventionsSurvival durationProcedure typeFrequent surveillanceHealthcare resourcesAssessing short- and long-term outcomes among black vs white Medicare patients undergoing resection of colorectal cancer
Schneider E, Haider A, Hyder O, Efron J, Lidor A, Pawlik T. Assessing short- and long-term outcomes among black vs white Medicare patients undergoing resection of colorectal cancer. The American Journal Of Surgery 2013, 205: 402-408. PMID: 23375764, PMCID: PMC3999705, DOI: 10.1016/j.amjsurg.2012.08.005.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overBlack or African AmericanCohort StudiesColectomyColorectal NeoplasmsFemaleHealth Status DisparitiesHospital MortalityHumansLength of StayLogistic ModelsMaleMedicareOdds RatioPatient ReadmissionProportional Hazards ModelsRectumSEER ProgramTreatment OutcomeUnited StatesWhite PeopleConceptsBlack patientsLong-term outcomesLong-term survivalColorectal cancerHospital mortalityWhite patientsGreater oddsWorse long-term survivalWhite Medicare patientsEnd Results-MedicareRisk of mortalityMore comorbiditiesPerioperative mortalityColorectal surgeryReduced oddsMedicare patientsInpatient dataPatientsReadmissionMortalityCancerComorbiditiesResectionWhite differencesOdds